Panel: Advances in the Treatment of Alzheimer’s & Other Cognitive Disorders
Panel Chairs:
Murali Gopalakrishnan, Global Head, Neuroscience Search & Evaluation, AbbVie, Inc;
Sumant Kulkarni, Managing Director Biotechnology Equity Research, Canaccord Genuity
Panelists:
Alexander Gebauer, Co-Founder & Executive Chairman, Galimedix Therapeutics;
Jenny Laird, VP, Search & Evaluation Neuroscience Eli Lilly;
John Alam, Founder & CEO, CerovoMed;
Lisa Ricciardi, President & CEO, Cognition Therapeutics;
Todd Haim, director, Offce of Strategic Extramural Programs, NIA